Gabelli Funds LLC Gilead Sciences, Inc. Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $174,823 - $199,410	-2,300 Reduced 8.05%	26,271 $2.02 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $264,860 - $380,247	-4,250 Reduced 12.95%	28,571 $2.45 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $226,728 - $258,982	-3,808 Reduced 10.4%	32,821 $2.03 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $132,756 - $149,523	2,300 Added 6.7%	36,629 $2.26 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $437,296 - $547,979	-7,550 Reduced 18.03%	34,329 $2.04 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $940,759 - $1.07 Million	-14,500 Reduced 25.72%	41,879 $3.04 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $135,380 - $146,060	2,000 Added 3.68%	56,379 $3.94 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $82,511 - $90,154	1,300 Added 2.45%	54,379 $3.75 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $641,520 - $731,974	-10,692 Reduced 16.77%	53,079 $3.43 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $1.95 Million - $2.23 Million	-34,500 Reduced 35.11%	63,771 $3.72 Million
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $37,260 - $46,848	-600 Reduced 0.61%	98,271 $6.21 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $651,060 - $756,000	9,000 Added 10.01%	98,871 $7.61 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.82 Million - $2.33 Million	29,100 Added 47.88%	89,871 $6.72 Million
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $264,308 - $296,391	-4,272 Reduced 6.57%	60,771 $4.11 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $389,280 - $454,080	-6,000 Reduced 8.45%	65,043 $4.61 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $145,680 - $177,600	-2,000 Reduced 2.74%	71,043 $5.36 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $4.87 Million - $5.72 Million	-68,457 Reduced 48.38%	73,043 $5.23 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $10.2 Million - $12.1 Million	141,500	141,500 $11.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account